[1]王 飞,祝 靳,赵宝林.溃疡性结肠炎患者血清LncRNA Mirt2 和LncRNA IFNG-AS1 表达水平及与预后相关性研究[J].现代检验医学杂志,2023,38(03):114-118+148.[doi:10.3969/j.issn.1671-7414.2023.03.020]
　WANG Fei,ZHU Jin,ZHAO Bao-lin.Study on the Expression Levels of Serum LncRNA Mirt2 and LncRNA IFNGAS1 in Patients with Ulcerative Colitis and Their Correlation with Prognosis[J].Journal of Modern Laboratory Medicine,2023,38(03):114-118+148.[doi:10.3969/j.issn.1671-7414.2023.03.020]
点击复制

溃疡性结肠炎患者血清LncRNA Mirt2 和LncRNA IFNG-AS1 表达水平及与预后相关性研究()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第38卷
期数:
2023年03期
页码:
114-118+148
栏目:
论著
出版日期:
2023-05-15

文章信息/Info

Title:
Study on the Expression Levels of Serum LncRNA Mirt2 and LncRNA IFNGAS1 in Patients with Ulcerative Colitis and Their Correlation with Prognosis
文章编号:
1671-7414（2023）03-114-06
作者:
王 飞; 祝 靳; 赵宝林
（南京市浦口区中医院/ 南京市中医院浦口分院肛肠科，南京 211800）
Author(s):
WANG Fei;  ZHU Jin;  ZHAO Bao-lin
（Department of Anorectal, Nanjing Pukou District Traditional Chinese Medicine Hospital/Nanjing Traditional Chinese Medicine Hospital Pukou Branch, Nanjing 211800, China）
关键词:
溃疡性结肠炎; 长链非编码RNA 心肌梗死相关转录本2; 长链非编码RNA 干扰素γ- 反义RNA1
分类号:
R574.62；R392.11
DOI:
10.3969/j.issn.1671-7414.2023.03.020
文献标志码:
A
摘要:
目的 探讨长链非编码RNA心肌梗死相关转录本2（long non-coding RNA myocardial infarction-related transcript 2，LncRNA Mirt2）、长链非编码RNA 干扰素γ- 反义RNA1（long non-coding RNA interferon γ-antisense RNA 1，LncRNA IFNG-AS1）在溃疡性结肠炎（ulcerative colitis，UC）患者血清中表达情况及与UC 患者预后相关性。方法 选择2018 年12 月～ 2021 年1 月南京市浦口区中医院（南京市中医院浦口分院）收治的193 例UC 患者作为观察对象，其中缓解期85 例，活动期108 例。根据患者预后情况分为复发组（n=78）和未复发组（n=115），另选取同期190例健康体检者作为对照组。采用实时荧光定量PCR（quantitative real-time PCR，qRT-PCR）检测血清LncRNA Mirt2 和LncRNA IFNG-AS1 表达水平，Pearson 法分析UC 患者血清LncRNA Mirt2 和LncRNA IFNG-AS1 表达水平相关性及LncRNA Mirt2 和LncRNA IFNG-AS1 与C- 反应蛋白（C-reactive protein，CRP）、白细胞介素-6 (interleukin- 6) 和肿瘤坏死因子-α(tumor necrosis factor- α，TNF-α) 的相关性；ROC 曲线分析血清LncRNA Mirt2 和LncRNA IFNG-AS1 对复发UC 的诊断价值。结果 与对照组比较，缓解期组与活动期组UC 患者血清LncRNA Mirt2（0.92±0.10，0.71±0.08vs 1.07±0.12）表达水平降低，LncRNA IFNG-AS1（1.63±0.25，2.27±0.42 vs 1.01±0.14）表达水平及CRP（13.42±4.71mg/L,25.38±6.29 mg/L vs 4.32±1.27 mg/L），IL-6（8.31±2.35pg/ml,16.55±4.52 pg/ml vs 2.87±0.78 pg/ml），TNF-α（15.38±4.29 pg/ml,28.94±6.37 pg/ml vs 8.42±1.63 pg/ml）水平升高，差异具有统计学意义（t=10.064 ～ 44.632，均P<0.001）；与缓解期组相比，活动期组UC 患者血清LncRNA Mirt2 表达水平降低，LncRNA IFNG-AS1 表达水平及CRP，IL-6，TNF-α 水平升高，差异具有统计学意义（t=12.420 ～ 16.844，均P<0.001）；与轻度组比较，中、重度组UC 患者血清LncRNA Mirt2（0.69±0.08，0.58±0.05 vs 0.81±0.06）表达水平降低，LncRNA IFNG-AS1（2.25±0.48，2.83±0.25 vs 1.90±0.31）表达水平升高，差异有统计意义（t=3.890 ～ 17.225，均P<0.001）；与中度组比较，重度组UC 患者血清LncRNA Mirt2 表达水平降低，LncRNA IFNG-AS1 表达水平升高，差异具有统计学意义（t=6.184，5.957，均P<0.001）。相关性分析显示，UC 患者血清LncRNA Mirt2 表达水平与CRP，IL-6 和TNF-α 呈负相关（r=-0.623，-0.605，-0.571，均P<0.001），LncRNA IFNG-AS1 表达水平与CRP，IL-6 和TNF-α 呈正相关（r=0.457，0.531，0.497，均P<0.001）。与未复发组比较，复发组UC 患者血清LncRNA Mirt2（0.70±0.08 vs 0.87±0.11）表达水平显著降低，LncRNA IFNG-AS1（2.38±0.41 vs 1.72±0.28）表达水平显著升高（t=11.706，13.294，均P<0.001）；血清LncRNAMirt2，LncRNA IFNG-AS1 联合诊断复发UC 的曲线下面积为0.931（95%CI：0.886 ～ 0.963），敏感度和特异度分别为87.18%，86.96%；阳性预测值、阴性预测值和准确度分别为81.93%，90.91% 和87.05%。结论 UC 患者血清LncRNAMirt2 表达水平降低、LncRNA IFNG-AS1 表达水平升高，与炎症水平和患者预后有关，可作为反映UC 患者病情与预后的标志物。
Abstract:
Objective To investigate the expression of long non-coding RNA myocardial infarction-related transcript 2 (LncRNA Mirt2) and long non-coding RNA interferon γ-antisense RNA 1 (LncRNA IFNG-AS1) in serum of patients with ulcerative colitis (UC) and their correlation with prognosis of UC patients. Methods A total of 193 UC patients admitted to Nanjing Pukou District Traditional Chinese Medicine Hospital (Nanjing Traditional Chinese Medicine Hospital Pukou Branch) from December 2018 to January 2021 were selected as observation objects including 85 cases in remission stage, 108 cases in active stage. According to the prognosis of patients, they were grouped into a recurrence group （n=78）and a non-recurrence group （n=115）. In addition, 190 healthy subjects were taken as the control group. The expression levels of serum LncRNA Mirt2 and LncRNA IFNG-AS1 were measured by Quantitative Real-time PCR (qRT-PCR) , the correlation between serum LncRNA Mirt2, LncRNA IFNG-AS1 expression levels, LncRNA Mirt2, LncRNA IFNG-AS1 and C-reactive protein , Interleukin-6(IL-6) and Tumor necrosis factor-α (TNF-α) were analyzed by Pearson method, and the diagnostic value of serum LncRNA Mirt2 and LncRNA IFNG-AS1 in recurrent UC was analyzed by ROC curve. Results Compared with the control group, the expression levels of serum LncRNA Mirt2 (0.92±0.10, 0.71±0.08 vs 1.07±0.12) in UC patients in the remission and active groups were decreased, LncRNA IFNG-AS1 (1.63±0.25, 2.27±0.42 vs 1.01±0.14) and CRP（13.42±4.71mg/L, 25.38±6.29 mg/L vs 4.32±1.27 mg/L）, IL-6（8.31±2.35pg/ml,16.55±4.52 pg/ml vs 2.87±0.78 pg/ml） and TNF-α（15.38±4.29 pg/ml, 28.94±6.37 pg/ml vs 8.42±1.63 pg/ml）levels increased, and the differences were statistically significant (t=10.064 ～ 44.632, all P<0.001）.Compared with the remission group, the serum LncRNA Mirt2 expression level of UC patients in the active group was decreased (0.71±0.08 vs 0.92±0.10), LncRNA IFNG-AS1 (2.27±0.42 vs 1.63±0.25) expression level and CRP, IL-6 and TNF-α levels increased, and the differences were statistically significant (t=12.420 ～ 16.844, all P<0.001). Compared with the mild group, the expression levels of serum LncRNA Mirt2 (0.69±0.08, 0.58±0.05 vs 0.81±0.06) in the moderate and severe UC patients were decreased, the expression level of LncRNA IFNG-AS1 (2.25±0.48, 2.83±0.25 vs 1.90±0.31) was increased, and the differences were statistically significant (t=3.890 ～ 17.225, all P<0.001). Compared with the moderate group, the severe the expression level of serum LncRNA Mirt2 in the UC patients in the group decreased, and the expression level of LncRNA IFNG-AS1 was increased, and the differences were statistically significant (t=6.184, 5.957, all P<0.001). Correlation analysis showed that serum LncRNA Mirt2 expression levels in UC patients were negatively correlated with CRP, IL-6 and TNF-α (r=- 0.623, -0.605, -0.571, all P<0.001), the expression level of LncRNA IFNG-AS1 was positively correlated with CRP, IL-6 and TNF-α (r=0.457, 0.531, 0.497, all P<0.001). Compared with the non-relapsed group, the serum LncRNA Mirt2 (0.70±0.08 vs 0.87±0.11) expression level of UC patients in the relapsed group was significantly decreased, and LncRNA IFNG-AS1 (2.38±0.41 vs 1.72±0.28) expression level was significantly increased (t=11.706, 13.294, all P<0.001). The area under the curve of serum LncRNA Mirt2 and LncRNA IFNG-AS1 for the diagnosis of recurrent UC was 0.931(95%CI: 0.886 ～ 0.963), the sensitivity, specificity were 87.18%, 86.96%, respectively, and the positive predictive value, negative predictive value, accuracy were 81.93%, 90.91% and 87.05%，respectively. Conclusion The expression level of LncRNA Mirt2 in serum of UC patients was decreased, and the expression level of LncRNA IFNG-AS1 was increased. They were related to the level of inflammation and the prognosis of patients, and may be used as markers to reflect the condition and prognosis of UC patients.

参考文献/References:

[1] 杨思贤, 慕奕彤, 牛福玉. 粪便S100A12, 钙卫蛋 白和乳铁蛋白对溃疡性结肠炎患者疾病活动度 和黏膜愈合评估价值分析[J]. 现代检验医学杂 志,2022,37(3):172-176. YANG Sixian, MU Yitong, NIU Fuyu. Evaluation value of stool S100A12, fecal calprotectin and lactoferrin for disease activity and mucosal healing in patients with ulcerative colitis [J]. Journal of Modern Laboratory Medicine, 2022, 37(3): 172-176.
[2] SINGH S , MURAD M H, FUMERY M , et al. Firstand second-line pharmacotherapies for patients with moderate to severely active ulcerative colitis: An updated network meta-analysis - science direct[J]. Clinical Gastroenterology and Hepatology, 2020,18(10):2179-2191.
[3] 邓颖, 朱宇珍, 吴科锋, 等．IL-6/STAT3 通路介导 LncRNAH19 上调在小鼠溃疡性结肠炎相关结直 肠癌发病中的作用[J]. 吉林大学学报（医学版）,2020, 46(1): 20-25,205. DENG Ying, ZHU Yuzhen, WU Kefeng, et al. Effect of LncRNA H19 up-regulation mediated by IL-6/STAT3 pathway in pathogenesis of ulcerative colitisassociated colorectal cancer in mice[J]. Journal of Jilin University(Medicine Edition), 2020, 46(1): 20-25, 205.
[4] DING Guangrong, MING Yuzheng, ZHANG Yuling. LncRNA Mirt2 is downregulated in ulcerative colitis and regulates IL-22 expression and apoptosis in colonic epithelial cells[J]. Gastroenterology Research and Practice, 2019, 2019:8154692.
[5] PADUA D, MAHURKAR-JOSHI S, LAW I K M, et al. A long noncoding RNA signature for ulcerative colitis identifies IFNG-AS1 as an enhancer of inflammation[J]. American Journal of Physiology. Gastrointestinal and Liver Physiology, 2016, 311(3): G446-G457.
[6] 吴开春, 梁洁, 冉志华, 等．炎症性肠病诊断与治疗 的共识意见（2018 年·北京）[J]. 中国实用内科杂志,2018, 38(9): 796-813． WU Kaichun, LIANG Jie, RAN Zhihua, et al. Chinese consensus on diagnosis and treatment of inflammatory bowel disease（Beijing, 2018）[J]. Chinese Journal of Practical Internal Medicine, 2018, 38(9): 796-813.
[7] WANG Ziye, KUN Yang, LEI Zhao, et al. LncRNA MIAT downregulates IL-1β, TNF-ɑ to suppress macrophage inflammation but is suppressed by ATPinduced NLRP3 inflammasome activation [J]. Cell Cycle, 2021, 20(2): 194-203.
[8] GENG Hua, BU Hengfu, LIU Fangyi, et al. In inflamed intestinal tissues and epithelial cells, interleukin 22 signaling increases expression of H19 long noncoding RNA, which promotes mucosal regeneration [J]. Gastroenterology, 2018, 155(1): 144-155.
[9] DU Meng, YUAN Lin, TAN Xin, et al. The LPS-inducible LncRNA Mirt2 is a negative regulator of inflammation [J]. Nature Communications, 2017, 8(1): 2049.
[10] PENG Huiyong, REN Shuting, LIU Yingzhao, et al. Elevated expression of the long noncoding RNA IFNG-AS1 in the peripheral blood from patients with rheumatoid arthritis [J]. J Immunol Res, 2020, 2020: 6401978.
[11] XU Yahuan, SHAO Bibo. Circulating LncRNA IFNGAS1 expression correlates with increased disease risk,higher disease severity and elevated inflammation in patients with coronary artery disease[J]. Journal of Clinical Laboratory Analysis, 2018, 32(7):e22452.
[12] LI Chenyang, CUI Lujia, LI Siqiong, et al. Long noncoding RNA Mirt2 interacts with long non-coding RNA IFNG-AS1 to regulate ulcerative colitis[J]. Experimental and Therapeutic Medicine, 2020, 20(5): 32.
[13] ZHANG X M, LI L B, SUN C H. The effect of myocardial infarction-associated transcript 2 (Mirt2) and miR-101 on sepsis-induced myocardial injury in rats[J]. European Review for Medical and Pharmacological Sciences, 2020, 24(11): 6299-6310.
[14] 吴斌, 梁文启, 王美堂. 脓毒症患者血清LncRNA IFNG-AS1 的表达及临床意义[J]. 实用医学杂志,2020, 36 (5):590-592. WU Bin, LIANG Wenqi, WANG Meitang. Expression and clinical significance of serum LncRNA IFNG-AS1 in sepsis patients [J]. The Journal of Practical Medicine,2020, 36(5): 590-592.
[15] 刘丽, 柳云恩．溃疡性结肠炎患者血清miR-15 表达 水平与炎性反应状态及预后的关系[J]. 国际消化病 杂志, 2020, 40(1): 41-46． LIU Li, LIU Yun’en. Relationship between the expression of serum miR-15 and inflammatory status and prognosis in patients with ulcerative colitis [J]. International Journal of Digestive Diseases, 2020,40(1): 41-46.
[16] LI Heng, FAN Chen, FENG Chunlan, et al. Inhibition of phosphodiesterase-4 attenuates murine ulcerative colitis through interference with mucosal immunity[J]. British Journal of Pharmacology, 2019, 176(13): 2209- 2226.
[17] 赵玉霞, 刘迎春, 张细元, 等. CD4 阳性T 细胞 分泌的Bcl2 L12 蛋白在小儿溃疡性结肠炎中促进 Th2 细胞活化对疾病进展的影响[J]. 中国免疫学杂 志,2020,36(12):1489-1493. ZHAO Yuxia, LIU Yingchun, ZHANG Xiyuan, et al. Effect of Bcl2 L12 protein secreted by CD4 positive T cells on Th2 cell activation in children with ulcerative colitis[J]. Chinese Journal of Immunology, 2020,36(12): 1489-1493.
[18] RANKIN C R, SHAO Ling, ELLIOTT J, et al. The IBD-associated long noncoding RNA IFNG-AS1 regulates the balance between inflammatory and anti-inflammatory cytokine production after T-cell stimulation[J]. American Journal of Physiology. Gastrointestinal and Liver Physiology, 2020, 318(1): G34-G40.

相似文献/References:

[1]杨思贤,慕奕彤,牛福玉.粪便S100A12，钙卫蛋白和乳铁蛋白对溃疡性结肠炎患者疾病活动度和黏膜愈合评估价值分析[J].现代检验医学杂志,2022,37(03):172.[doi:10.3969/j.issn.1671-7414.2022.03.036]
　YANG Si-xian,MU Yi-tong,NIU Fu-yu.Evaluation Value of Stool S100A12, Fecal Calprotectin and Lactoferrin for Disease Activity and Mucosal Healing in Patients with Ulcerative Colitis[J].Journal of Modern Laboratory Medicine,2022,37(03):172.[doi:10.3969/j.issn.1671-7414.2022.03.036]
[2]关李稳,刘真义,周真真,等.溃疡性结肠炎患者血清LncRNA TUG1 和miR-142-5p 表达与疾病活动度及预后的关系[J].现代检验医学杂志,2023,38(05):70.[doi:10.3969/j.issn.1671-7414.2023.05.013]
　GUAN Liwen,LIU Zhenyi,ZHOU Zhenzhen,et al.Relationship between Serum LncRNA TUG1 and miR-142-5p Expression and Disease Activity and Prognosis in Patients with Ulcerative Colitis[J].Journal of Modern Laboratory Medicine,2023,38(03):70.[doi:10.3969/j.issn.1671-7414.2023.05.013]
[3]王 燕a,胡秀娟a,张 丽a,等.溃疡性结肠炎患者血清Elabela，LRG1水平表达与疾病活动指数的相关性研究[J].现代检验医学杂志,2024,39(01):100.[doi:10.3969/j.issn.1671-7414.2024.01.018]
　WANG Yana,HU Xiujuana,ZHANG Lia,et al.Correlation between the Expression of Serum Elabela, LRG1 Levels and Disease Activity Index in Patients with Ulcerative Colitis[J].Journal of Modern Laboratory Medicine,2024,39(03):100.[doi:10.3969/j.issn.1671-7414.2024.01.018]
[4]沈丹丹,王 鸿.溃疡性结肠炎活动期患者血清TRIM22 和KLF2 水平与病情及临床结局的关系[J].现代检验医学杂志,2024,39(04):143.[doi:10.3969/j.issn.1671-7414.2024.04.026]
　SHEN Dandan,WANG Hong.Relationship among Serum TRIM22 and KLF2 Levels, Disease Condition and Clinical Outcome of Patients with Active Ulcerative Colitis[J].Journal of Modern Laboratory Medicine,2024,39(03):143.[doi:10.3969/j.issn.1671-7414.2024.04.026]

备注/Memo

备注/Memo:
基金项目：南京市浦口区社会事业科技发展计划项目（S2021-22）。
作者简介：王飞（1979-），男，硕士研究生，副主任中医师，主要从事中西医结合肛肠病临床研究，E-mail：wangfei123wf@126.com。
通讯作者：祝靳，E-mail：1225875512@qq.com。
更新日期/Last Update: 2023-05-15